How Are Illicit Drugs Classified Under Federal Law?

Under federal law, illicit drugs are classified through the Controlled Substances Act of 1970, which sorts every controlled substance into one of five schedules based on three criteria: the drug’s potential for abuse, whether it has an accepted medical use in the United States, and its likelihood of causing physical or psychological dependence.¹ Schedule I carries the tightest restrictions; Schedule V the loosest. Where a substance lands controls whether a doctor can prescribe it, how pharmacies must handle it, and how severely federal law punishes anyone who makes, sells, or possesses it.²

The DEA publishes the full, updated list of scheduled substances every year in the Code of Federal Regulations.³ The list is long and changes as new substances appear, so the framework matters more than any single entry.

The Five Schedules

Each schedule reflects a different balance between abuse risk and medical value. The higher the schedule number, the lower the perceived danger and the more freely the substance can be dispensed.

Schedule I

Schedule I is reserved for substances the federal government considers to have a high abuse potential, no accepted medical use, and no safe way to use even under a doctor’s supervision.² These drugs cannot legally be prescribed, and research requires special DEA registration. Examples include heroin, LSD, MDMA, peyote, and marijuana.⁴

Marijuana’s placement here is the most contested part of the system. As of early 2026, cannabis remains Schedule I under federal law despite a 2024 proposed rulemaking that would move it to Schedule III. That proposal is still pending, with no final rule published. State legalization does not change the federal classification: federal law still treats marijuana possession, sale, and cultivation as criminal offenses even where state authorities decline to prosecute.

Schedule II

Schedule II drugs also carry a high abuse potential, but they have an accepted medical use, sometimes under tight restrictions, and their abuse can lead to severe physical or psychological dependence.² Fentanyl, oxycodone, methamphetamine, cocaine (used medically as a local anesthetic), Adderall, and Ritalin all sit here.⁴ Doctors generally cannot phone in Schedule II prescriptions, refills are not permitted on the same prescription, and pharmacies face strict recordkeeping rules.

Schedule III

Schedule III substances have a lower abuse potential than those in Schedules I and II, an accepted medical use, and abuse tends to produce moderate physical dependence or high psychological dependence.² Examples include codeine products with less than 90 milligrams per dose (such as Tylenol with codeine), ketamine, anabolic steroids, and testosterone.⁴ Prescriptions may be refilled up to five times within six months of the original date.

Schedule IV

Schedule IV substances carry a low abuse potential compared with Schedule III and a limited risk of dependence.² Widely prescribed medications for anxiety and sleep, including alprazolam (Xanax), diazepam (Valium), zolpidem (Ambien), and tramadol, are Schedule IV.⁴ Refill rules match Schedule III.

Schedule V

Schedule V has the least restrictive controls. These substances have the lowest abuse potential among controlled drugs and typically contain small amounts of narcotics. Cough syrups with limited concentrations of codeine (such as Robitussin AC) and Lyrica (pregabalin) are examples.⁴ Some Schedule V products may be sold without a prescription in certain states, though a pharmacist is often involved in the sale.

How a Substance Gets Scheduled or Moved

The list is not fixed. The DEA can add new substances, move existing ones between schedules, or remove them altogether.¹ The process can be initiated by the DEA, by the Department of Health and Human Services, or by a petition from anyone, including drug manufacturers, medical associations, or private citizens.

Before proposing a change, the DEA must request a scientific and medical evaluation from HHS. That evaluation carries real weight. If HHS recommends that a substance should not be controlled at all, the DEA cannot schedule it. HHS’s medical and scientific findings bind the DEA.⁵

The Attorney General must weigh eight factors when evaluating a substance:

Its actual or relative potential for abuse
Scientific evidence of its pharmacological effect
The current state of scientific knowledge about the substance
Its history and current pattern of abuse
The scope, duration, and significance of that abuse
The risk it poses to public health
Its psychic or physiological dependence liability
Whether it is an immediate precursor to a substance already controlled

After the evaluation, the DEA publishes a proposed rule in the Federal Register, opens a public comment period, and may hold a formal hearing. Only then does the agency publish a final rule setting the schedule.⁵

Emergency Scheduling

When a new substance poses an immediate danger, the DEA can bypass most of that process. Emergency scheduling lets the agency temporarily place a substance in Schedule I for up to two years, with a possible one-year extension, while the standard evaluation runs. The DEA used this power in 2018 to temporarily schedule entire classes of fentanyl-related substances after synthetic opioid deaths surged, and Congress has repeatedly extended that order.⁶

Designer Drugs and the Analogue Act

Chemists routinely create new substances designed to mimic controlled drugs while sidestepping the exact chemical definitions in the schedules. The Federal Analogue Act treats any substance “substantially similar” to a Schedule I or II drug as a Schedule I substance, as long as it is intended for human consumption.⁷

Prosecutors prove that intent through factors like how the substance was marketed, its price compared with legitimate products, and whether it moved through clandestine channels. Labeling a product “not for human consumption” is not a shield. The statute expressly says labeling alone is not enough to show a substance was not intended to be consumed.⁷

What the Schedule Means for Penalties

A drug’s schedule directly drives how harshly federal law punishes anyone who manufactures, distributes, or possesses it. Penalties escalate based on the substance, the quantity, and the offender’s criminal history.

Manufacturing and Distribution

For Schedule I and II substances, penalties depend heavily on the specific drug and quantity. At the top tier, distributing large quantities of heroin, cocaine, fentanyl, or methamphetamine carries a mandatory minimum of 10 years and up to life, with fines reaching $10 million for an individual. If someone dies from using the distributed substance, the mandatory minimum rises to 20 years. A second offense after a prior serious drug felony conviction pushes the minimum to 15 years; a third such conviction triggers 25 years.⁸ Smaller quantities of the same drugs carry a 5-year mandatory minimum and up to 40 years.

Schedule III distribution offenses carry up to 10 years, Schedule IV up to 5 years, and Schedule V up to 1 year, with fines decreasing at each level. These are federal baselines. State charges for the same conduct often add their own consequences.

Simple Possession

Federal law treats simple possession more leniently than distribution, but the consequences are real. A first offense for possessing any controlled substance carries up to one year in prison and a minimum $1,000 fine. A second offense raises the ceiling to two years with a minimum $2,500 fine. A third or subsequent offense means up to three years and a minimum $5,000 fine.⁹ Courts cannot suspend or defer the minimum sentences for repeat offenders.

Effect-Based Categories

Legal scheduling is one classification. Pharmacologists and treatment professionals also group substances by what they do to the brain and body, and readers often encounter both systems in the same conversation. A drug’s schedule tells you how the law treats it; its pharmacological category tells you how it acts.

Stimulants speed up the central nervous system, raising energy, alertness, heart rate, and blood pressure. Cocaine, methamphetamine, and prescription amphetamines like Adderall are stimulants.

Depressants slow brain activity, producing relaxation and drowsiness while also slowing breathing and heart rate. Benzodiazepines like Valium and Xanax, barbiturates, and alcohol fall in this group.

Opioids bind to specific brain receptors to block pain and produce euphoria, and they suppress breathing, which is the mechanism behind overdose deaths. Heroin, fentanyl, oxycodone, and hydrocodone are opioids.

Hallucinogens distort perception, often causing visual and auditory hallucinations and altered sense of time. LSD and psilocybin are the best-known examples. They rarely produce physical dependence but can trigger severe anxiety or psychotic episodes.

Dissociatives create a sense of detachment from body and surroundings rather than altering perception directly. PCP, ketamine, and dextromethorphan (DXM) at high doses are common examples. Several were originally developed as surgical anesthetics.

1
Drug Enforcement Administration. The Controlled Substances Act
2
Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
3
Diversion Control Division. Controlled Substance Schedules
4
Drug Enforcement Administration. Drug Scheduling
5
Office of the Law Revision Counsel. 21 USC 811 – Authority and Criteria for Classification of Substances
6
Federal Register. Schedules of Controlled Substances – Placement of Nine Specific Fentanyl-Related Substances
7
Office of the Law Revision Counsel. 21 USC 813 – Treatment of Controlled Substance Analogues
8
Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts
9
Office of the Law Revision Counsel. 21 USC 844 – Penalties for Simple Possession